Ipamorelin, CJC-1295 and Sermorelin: Identity Distinctions

Scope of this reference

This page concerns laboratory catalogue identity, terminology and documentation. It is not a treatment guide, a recommendation, a human-use protocol or evidence that a listed material is safe or effective in people or animals.

Keep identity, analytical results and biological evidence separate

A catalogue name identifies the material being offered. An analytical report can provide evidence about the identity, measured composition or purity of the particular sample tested. Neither of those facts establishes a therapeutic, preventative, cosmetic or physiological outcome.

Published studies must also be read according to their actual model. Findings from an assay, cell line, isolated tissue or animal model cannot be presented as a demonstrated human outcome. Results concerning a related molecule, full-length protein, salt form or pharmaceutical product cannot automatically be transferred to a separately listed research material.

What to check in the catalogue

• •the full material name and SKU
• •the supplied quantity and physical form
• •the batch number on the material
• •whether an analytical report is available for that same batch
• •the test method, laboratory, date and limitations stated in the report

Our COA library publishes available reports as issued. The guides to reading a peptide COA and understanding HPLC purity explain what those documents can and cannot show.

Laboratory-use boundary

Materials sold on this site are supplied solely for non-clinical in-vitro laboratory research. They must not be ingested, injected, inhaled, applied or otherwise administered to a human or animal.

We do not provide dosing, routes of administration, treatment guidance, cosmetic-use guidance or in-vivo protocols. Preparation, storage and handling must follow a validated institutional SOP, the material documentation and an appropriate risk assessment.